Australian (ASX) Pharmaceuticals & Biotech Dividend Stocks
UPDATED Mar 01, 2026
Discover Australian Pharmaceuticals & Biotech High Yield Dividend Stocks that are on the ASX and sorted by Dividend Yield. An upper limit of 20% is in place to filter out stocks with potentially unsustainable dividends. All companies with high dividend yields (above 5%) should be researched for sustainability. For more options please click on 'Advanced Filters'.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
VLS | AU$2.69 | 5.5% | 46.2% | AU$149.0m | n/a | 14.3 | n/a | 5.2% | ||
VIT | AU$0.042 | -14.3% | -44.0% | AU$27.8m | n/a | 35.5 | n/a | 4.8% | ||
CSL | AU$147.30 | -0.05% | -43.8% | AU$70.9b | AU$209.66 | 36.0 | 29.7% | 2.8% | ||
CUV | AU$10.00 | -11.7% | -18.2% | AU$502.0m | AU$23.38 | 15.4 | 27.1% | 0.5% | ||
CTE | AU$1.25 | 4.2% | 66.7% | AU$61.0m | n/a | 27.9 | n/a | 0% | ||
ACR | AU$0.012 | -14.3% | -53.8% | AU$4.9m | n/a | 1.8 | n/a | 0% | ||
MVP | AU$0.44 | -2.2% | -31.3% | AU$49.6m | AU$2.02 | 1.2 | 79.5% | 0% |
Page 1 of 1